|SPECIAL FEATURE: COMMENTARY
|Year : 2021 | Volume
| Issue : 1 | Page : 58-61
The dilemma of intimacy and other social stigmas associated with HIV-AIDS and COVID-19
Independent Public Health Researcher, Bhubaneswar, Odisha, India
|Date of Submission||23-Oct-2020|
|Date of Acceptance||07-Dec-2020|
|Date of Web Publication||4-Mar-2021|
Independent Public Health Researcher, C/O. Mr Bijaya Ketan Samal, Pansapalli, Bangarada (PO), Gangapur (Via), Ganjam 761 123, Odisha
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Samal J. The dilemma of intimacy and other social stigmas associated with HIV-AIDS and COVID-19. J Clin Sci Res 2021;10:58-61
Cases of pneumonia with unknown aetiology got reported in Wuhan city of Hubei province, China, by the last week of December 2019. These cases started spreading to different parts of China and other parts of the world after some days. It was then observed that most of these cases do have a contact of a history of seafood market of Huanan city. Many of these cases were reported with fever and cough. The novel coronavirus was identified from the throat swab of one of the patients by the Chinese Center for Disease Control and Prevention on 7 January 2020. The virus was subsequently named the 2019 nCoV by the World Health Organization (WHO). The WHO declared it as a public health emergency of international concern (PHEIC) looking at the grave situation that the virus started impacting. On February 11 , 2020, the causative agent was renamed the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses. Subsequently, the disease was renamed the coronavirus disease 2019 (COVID-19). Several achievements have already been attained in the fight against this monster especially in the front of virus identification, understanding clinical manifestations and diagnosis of the disease, however no effective treatment has been found out till date.,,
| Concept of Social Stigma|| |
Stigma is the occurrence of labelling, stereotyping, separation, loss of status and discrimination in the context in which power is exercised. Furthermore, as stigma incorporates the concepts of labelling and stereotyping, it is different from discrimination. Stigma, in the context of public health, is a well-evidenced hindrance to health-seeking behaviour, engagement to care and treatment adherence across a range of health problems globally. According to Goffman, stigma enables a variety of discriminations that culminate in the denial of social acceptance to an individual or a group, reduces opportunities and fuels social inequality., Furthermore, stigma adversely influences the health outcomes by worsening, undermining and impeding a number of social processes such as psychological and behavioural responses, relationships in social sphere, stress, availability of resources and aggravation of poor health. There are certain factors that influence the outcome among the affected individuals, groups and institutions that ultimately impact the health and the society because of stigmatisation. These factors include drivers and facilitators, stigma 'marking' and stigma manifestation. The drivers vary with the health conditions, however they are mostly the negative ones and may range from fear of infection through contact for communicable disease, loss of production in chronic conditions, to authoritarianism, social judgement and blame. On the contrary, facilitators could be either positive or negative influences, for instance, the presence or absence of personal protective equipment may minimise or exacerbate the stigmatising behaviour towards people with infectious disease by healthcare providers. The drivers and facilitators determine the 'marking of stigma' to specific individuals or groups. Once stigma is applied, it manifests in a range of experiences and practices. The manifestations could be 'self-stigma', 'perceived stigma', 'anticipated stigma' and 'associative stigma'.,,,
| Relationship Between Stigma Associated with HIV and COVID-19|| |
Understanding of the historical construct of stigma associated with HIV-AIDS can inform stigma mitigation of COVID-19. Let us look at the different facets that are associated with COVID-19 stigmatisation among people and the connection with HIV-AIDS. Evidences suggest that the practice of 'othering', a concept that defines as separate, distant and disconnected from the host communities. can result in social distancing through reduced interaction with the stigmatised people. Incidentally, the suggested public health measure to prevent the transmission of COVID-19 is the practice of social distancing. Albeit social distancing is an integral part of containment, how is this ensured that this activity does not exacerbate stigma and discrimination? Putting social distancing in the context of HIV-AIDS may not have a direct relevance, however intimacy and physical contact during the pandemic of HIV-AIDS could be better understood. During the epidemic period of HIV-AIDS, there was long contended tension between negotiating intimacy among partners. One of the publications during the HIV-AIDS epidemic in 1983 – 'How to have sex in an epidemic: One approach' – explored care, love and intimacy as reasons for safer sex motivation. The most significant message through this publication is that if affection informs sexual relationship, there exists a motivation to protect each other from the disease. Similarly, as per the suggestions of the UNAIDS and WHO, building connections via caring and kindness, leaving the fear of contracting COVID-19 behind, can motivate people to involve in non-stigmatising social-distancing behaviour., In the case of COVID-19, it is clearly known that the disease is not transmitted through sexual mode of transmission, however the droplet infection and infection through contact mode and the measures to contain the infection through quarantine and isolation hinder physical intimacy. All these measures can have a negative impact in making love and physical intimacy among the partners as the same can pose a potential risk of transmission of COVID-19. This can, to some extent, also negatively impact the relationship among the partners in some communities.
Furthermore, it is evident from the multiple bodies of HIV-related stigma research that multiple dimensions of stigma can negatively impact health practices and outcomes. Thus, COVID-19 stigma mitigation should take into account acts of discrimination and mistreatment, demeaning community norms and values; the ways in which persons accept negative perspectives towards a group they belong to and concerns that one will receive future bias and discrimination. In addition, there are international crises in relation to fund crunch for HIV and other health-related issues as well;, thus, it becomes imperative, at the present juncture of COVID-19 emergency, to harness political investment in challenging social inequities including that which exacerbate the COVID-19's impact on refugees and immigrants. According to the United Nations High Commissioner for Refugees, of the 196 countries affected by the pandemic of COVID-19, 79 countries are refugee-hosting countries reporting local transmission. COVID-19 is going to inevitably spread to these highly vulnerable displaced groups which needs urgent attention with the past experience of SARS, MERS and Ebola as well.
There are documented evidences that social disparities lead to health disparities. Evidences show that stigma unduly impacted depression among newly diagnosed HIV cases and lesbian, gay, bisexual, and transgender persons., Albeit the status of similar research in the field of COVID-19 is at the nascent stage, it will also have analogous mental health impacts including on healthcare providers.,
Thus, it becomes imperative that public health strategies directed towards mitigating stigma associated with COVID-19 should take into account multiple factors that lead to bias and discrimination. These multi-level strategies can address stigma drivers and facilitators. In addition, public health players should challenge the languages that create stigmatisation in public health messaging and in media., COVID-19 stigma mitigation strategies should apply a multisectoral lens that intersects with gender, race, immigration status, housing status and health status among others. Public health actors should balance between the bioscientific approach and psychosocial approach in preventing and controlling the pandemic of COVID-19. This would inform immediate and remote strategies to build empathy and social justice in the current situation and may do so in future pandemics as well.
Albeit the characteristic features of these two diseases are different, these two diseases share some common characteristic features in relation to social stigma associated with these two diseases, which could effectively be applied to either one of them and more specifically to COVID-19 to aid in the control and prevention of the disease. It has been more than three decades now since the pandemic of HIV-AIDS, and much is now known to the world and much research on social stigma associated with HIV-AIDS has ushered the ways and means to mitigate the global pandemic of HIV-AIDS. Many of them can be applied to the pandemic of COVID-19, thus it is significant to apply such experiences in mitigating the stigma and discrimination that are associated with COVID-19. This will aid in the control and prevention of COVID-19. In addition to HIV-AIDS social stigma is also associated with many other diseases like SARS, MERS, Ebola, among others. Thus, the lesions learnt from these epidemics should also be applied in other situations as appropriate.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al
. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England) 2020;395:497-506.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al.
Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, china. JAMA 2020;323:1061-9.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al.
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020;395:507-13.
Zarocostas J. What next for the coronavirus response? Lancet 2020;395:401.
International Committee on Taxonomy of Virus. Naming the 2019 Coronavirus; 2020. Available from: https://talk.ictvonline.org/
. [Last accessed on 2020 May 31].
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al.
Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med 2020;382(13):1199-207.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al.
Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-20.
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al.
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
. Cell Res 2020;30:269-71.
Link BG, Phelan JC. Conceptualizing stigma. Ann Rev Soc 2001;27:363-85.
Phelan JC, Link BG, Dovidio JF. Stigma and prejudice: One animal or two? Soc Sci Med 2008;67:358-67.
Link B, Hatzenbuehler ML. Stigma as an unrecognized determinant of population health: Research and policy implications. J Health Polit Policy Law 2016;41:653-73.
Goffman E. Stigma: Notes on the management of spoiled identity. New York: Simon and Schuster; 2009.
Parker R, Aggleton P. HIV and AIDS-related stigma and discrimination: A conceptual framework and implications for action. Soc Sci Med 2003;57:13-24.
Hatzenbuehler ML, Phelan JC, Link BG. Stigma as a fundamental cause of population health inequalities. Am J Public Health 2013;103:813-21.
Stangl AL, Earnshaw VA, Logie CH, van Brakel W, C Simbayi L, Barré I, et al.
The health stigma and discrimination framework: A global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Med 2019;17:31.
Stangl AL, Brady L, Fritz K. Measuring HIV Stigma and Discrimination: Technical Brief. Washington DC: International Centre for Research on Women; 2012.
Stangl AL, Lloyd JK, Brady LM, Holland CE, Baral S. A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: How far have we come? J Int AIDS Soc 2013;16 Suppl 2:3.
Rao D, Desmond M, Andrasik M, Rasberry T, Lambert N, Cohn SE, et al.
Feasibility, acceptability, and preliminary efficacy of the unity workshop: An internalized stigma reduction intervention for African American women living with HIV. AIDS Patient Care STDS 2012;26:614-20.
Zelaya CE, Sivaram S, Johnson SC, Srikrishnan AK, Suniti S, Celentano DD, et al.
Measurement of self, experienced, and perceived HIV/AIDS stigma using parallel scales in Chennai, India. AIDS Care 2012;24:846-55.
Quinn DM, Chaudoir SR. Living with a concealable stigmatized identity: The impact of anticipated stigma, centrality, salience, and cultural stigma on psychological distress and health. J Pers Soc Psychol 2009;97:634-51.
Holzemer WL, Makoae LN, Greeff M, Dlamini PS, Kohi TW, Chirwa ML, et al.
Measuring HIV stigma for PLHAs and nurses over time in five African countries. SAHARA J 2009;6:76-82.
Grove NJ, Zwi AB. Our health and theirs: Forced migration, othering, and public health. Soc Sci Med 2006;62:1931-42.
Goffman E. Stigma: Notes on the Management of Spoiled identity. New York: Simon & Shuster; 1963.
Lewnard JA, Lo NC. Scientific and ethical basis for social-distancing interventions against COVID-19. Lancet Infect Dis 2020;20:631-3.
Lancet T. COVID-19: Learning from experience. Lancet 2020;395:1011.
Logie CH, Turan JM. How do we balance tensions between COVID-19 public health responses and stigma mitigation? Learning from HIV research. AIDS Behav 2020;24:2003-6.
Berkowitz R, Callen M, Dworkin R. How to Have Sex in an Epidemic: One Approach. New York: News From the Front Publications; 1983.
Turan B, Hatcher AM, Weiser SD, Johnson MO, Rice WS, Turan JM, et al.
Framing mechanisms linking HIV-related stigma, adherence to treatment, and health outcomes. Am J Public Health 2017;107:863-9.
United Nations Population Fund. Humanitarian Action 2019 Overview. UNPFA. 2019. Available from: www.unfpa.org/humanitarian-action-2019-overview. [Last accessed on 2020 Apr 23].
Daniels JP. Venezuelan migrants “struggling to survive” amid COVID-19. Lancet 2020;395:1023.
Page KR, Venkataramani M, Beyrer C, Polk S. Undocumented US immigrants and COVID-19. N Engl J Med 2020;382:e62.
UNHCR. Coronavirus Emergency Appeal: UNHCR's Preparedness and Response Plan (Revised); 30 March, 2020.
Lau LS, Samari G, Moresky RT, Casey SE, Kachur SP, Roberts LF, et al.
COVID-19 in humanitarian settings and lessons learned from past epidemics. Nat Med 2020;26:647-8.
Bhatia R, Hartman C, Kallen MA, Graham J, Giordano TP. Persons newly diagnosed with HIV infection are at high risk for depression and poor linkage to care: Results from the steps study. AIDS Behav 2011;15:1161-70.
Logie CH, Lacombe-Duncan A, Wang Y, Levermore K, Jones N, Ellis T, et al.
Adapting the psychological mediation framework for cisgender and transgender sexual minorities in Jamaica: Implications from latent versus observed variable approaches to sexual stigma. Soc Sci Med 2020;245:112663.
Ho CS, Chee CY, Ho RC. Mental health strategies to combat the psychological impact of COVID-19 beyond paranoia and panic. Ann Acad Med Singap 2020;49:155-60.
Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, et al.
Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open 2020;3:e203976.
Sontag S. Illness as Metaphor. New York: Farrar, Straus and Giroux; 1978.
Jones DS. History in a crisis-lessons for COVID-19. Engl J Med 2020;382:1681-3.